As of 2025-09-13, the Intrinsic Value of Pliant Therapeutics Inc (PLRX) is -16.86 USD. This PLRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.65 USD, the upside of Pliant Therapeutics Inc is -1,121.59%.
Based on its market price of 1.65 USD and our intrinsic valuation, Pliant Therapeutics Inc (PLRX) is overvalued by 1,121.59%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.86 - -16.86 | -16.86 | -1,121.59% |
| P/E | (70.12) - (71.13) | (70.37) | -4365.1% |
| DDM - Stable | (44.38) - (206.07) | (125.22) | -7689.2% |
| DDM - Multi | (43.56) - (156.61) | (68.08) | -4226.0% |
| Market Cap (mil) | 101.29 |
| Beta | 1.22 |
| Outstanding shares (mil) | 61.39 |
| Enterprise Value (mil) | 44.83 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.40% |
| Cost of Debt | 5.00% |
| WACC | 6.62% |